Xiangyu Medical Co.,Ltd (SHA:688626)
China flag China · Delayed Price · Currency is CNY
41.95
-0.10 (-0.24%)
Sep 30, 2026, 3:00 PM CST

Xiangyu Medical Co.,Ltd Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
753.6740.75733.63736.61483.87515.8
Other Revenue
28.27279.98.24.667.7
781.87767.75743.53744.81488.53523.5
Revenue Growth
2.24%3.26%-0.17%52.46%-6.68%5.65%
Cost of Revenue
273.75266.19252.61243.35170.08169.57
Gross Profit
508.12501.56490.92501.46318.44353.92
Selling, General & Admin
292.63296.28274.02210.41175.89140.42
Research & Development
171.19175.06152.02106.7592.4168.61
Other Operating Expenses
1.83-8.36-7.5-9-3.60.55
Operating Expenses
470.45465.25421.73310.31264.77211.78
Operating Income
37.6736.3169.19191.1553.67142.15
Interest Expense
-4.47-5.7-3.63-2.66-0.19-
Interest & Investment Income
25.728.9526.638.8237.5933.73
Currency Exchange Gain (Loss)
-0.55-0.190.070.020.02-0.02
Other Non Operating Income (Expenses)
-1.24-2.211.042.392.612.16
EBT Excluding Unusual Items
57.1157.1793.27229.7293.7178.02
Gain (Loss) on Sale of Investments
1.090.5--3.24-1.06-
Gain (Loss) on Sale of Assets
0.130.030.070.01--0.01
Asset Writedown
-0.18-0.18-0.05-0.02-0.25-
Other Unusual Items
20.5816.9213.9517.5540.644.72
Pretax Income
78.7374.43107.24244.03132.99222.72
Income Tax Expense
-3.67-1.564.3815.729.723.18
Earnings From Continuing Operations
82.475.99102.85228.31123.3199.54
Minority Interest in Earnings
0.022.170.09-1.172.172.36
Net Income
82.4278.16102.94227.14125.47201.9
Net Income to Common
82.4278.16102.94227.14125.47201.9
Net Income Growth
0.88%-24.08%-54.68%81.03%-37.85%2.87%
Shares Outstanding (Basic)
153153156158159150
Shares Outstanding (Diluted)
153153156158159150
Shares Change
-1.10%-1.75%-1.12%-0.68%6.20%24.97%
EPS (Basic)
0.540.510.661.440.791.35
EPS (Diluted)
0.540.510.661.440.791.35
EPS Growth
2.00%-22.73%-54.17%82.28%-41.48%-17.68%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-30.39-97.37-260.3-251.35-16.3731.97
Free Cash Flow Per Share
-0.20-0.64-1.67-1.59-0.100.21
Dividend Per Share
0.1800.1800.2400.5300.2400.380
Dividend Growth
-25.00%-25.00%-54.73%120.90%-36.84%2.70%
Gross Margin
64.99%65.33%66.03%67.33%65.18%67.61%
Operating Margin
4.82%4.73%9.30%25.66%10.99%27.15%
Profit Margin
10.54%10.18%13.84%30.50%25.68%38.57%
Free Cash Flow Margin
-3.89%-12.68%-35.01%-33.75%-3.35%6.11%
EBITDA
89.3886.46107.01208.5769.74153.52
EBITDA Margin
11.43%11.26%14.39%28.00%14.27%29.33%
D&A For EBITDA
51.7150.1537.8217.4116.0611.37
EBIT
37.6736.3169.19191.1553.67142.15
EBIT Margin
4.82%4.73%9.30%25.66%10.99%27.15%
Effective Tax Rate
--4.09%6.44%7.29%10.41%
Revenue as Reported
781.87767.75743.53744.81488.53523.5